News & Events

Read the latest updates on APIE Therapeutics.



IPF Summit 2022

August 29, 2022
During the IPF Summit, APIE Therapeutics presented a poster describing the novel apelin receptor agonist…

International Workshop of Scleroderma Research

August 2, 2022
Preclinical results support the potential of APT-101 as a therapeutic for ILD, including those cases…

APIE Therapeutics chosen as Start-Up Stadium Finalist

June 15, 2022
Start-Up Stadium was designed to provide start-up companies with the opportunity to access key members…


January 11, 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors with strategic…